Since 2006, our purpose has been to empower GameChangers. What does this mean to us? It means discovering the innovators, the scientists, and inventors, and helping them turn their vision into a reality and their business into an international success story.
Today, we’re doubling down on this purpose with the announcement of our sixth early-stage fund - $200M redalpine Capital VII (RAC VII). RAC VII is a milestone fund for a number of reasons. It’s our largest yet, which gives us even more means to back a new generation of founders and unlock the economic potential of innovation. Not only that, but we closed it in the middle of a turbulent market, and the fact that the fund was oversubscribed is a clear sign of our investors’ trust in our almost 20-year track record and consistent top-quartile returns.
To our investors: Thank you for your belief in us and continued support in our investment strategy at the continuum of software and science. To our founders: Thank you for showing us time and time again that you are true GameChangers and for recognizing that we are the right partners in your journey to making a real impact.
This $200M fund did not come out of nowhere. It’s the result of a team effort and clear strategy that dates back to our first days as a company in 2006. Founded in Zurich by an entrepreneur and a molecular biologist, the combination of software and science has been in our blood since the very beginning. This focus is reflected in our investment approach and our team (half are scientists, including doctors, physicists, biologists, material scientists and more, the other half are operators and entrepreneurs). With so many experts on the team, we’re able to interact with scientific founders on eye level and understand and challenge the science at the deepest levels. This enables us to go deep into the frontiers of tech in Europe.
a new generation
RAC VII will continue our tradition of backing European companies with what we call a “tech hedge”—a significant, defensible advantage that is 10x better than their competitors. We believe that now, more than ever, is the ideal time to invest in these kinds of companies. We are at a pivotal moment in technological development, with transformative changes converging across all industries. AI is reshaping the way we work and live, and as a fund with a long history investing in the continuum of software and science, we are particularly excited about new AI applications, as well as the latest breakthroughs in computer science that will propel the field forward.
These groundbreaking developments are already evident in our portfolio, including the nine companies we've invested in through RAC VII. More than half have an AI-first approach, while all others have significant AI integrations. These startups are tackling some of the world’s biggest challenges, from Proxima Fusion (Germany), a spin-off from the Max Planck Institute for Plasma Physics focused on clean energy production through fusion technology, to Expression Edits (UK), a gene-editing company accelerating the development of life-saving therapies. As we continue building this portfolio, with plans to invest in 15-20 early-stage startups and help them scale globally, we remain committed to our long-term partnerships.
This commitment is at the core of redalpine. Historically, we have supported the majority of our startups across multiple funding rounds, and over 75% of our seed companies advance to a Series A round, far surpassing the European average of just over 20% (according to Dealroom data). To double-down even further, we launched our multi-stage Summit Fund to provide the means to back our portfolio superstars all the way to pre-IPO, reducing reliance on US funding in the later stages.
why London, and why now
In combination with our new fund, our expansion to London marks another significant step in our evolution as a truly pan-European fund. From the outset, we’ve been bullish on Europe. We firmly believe that the ecosystem has all the ingredients for success and is evolving rapidly, yet remains underrated. Seven of the world’s 10 most innovative countries are in Europe, and the number of local unicorns is growing exponentially.
Given this momentum, launching an office in London was the natural next step in our growth journey, especially after our expansion to Berlin. London, with its rich history of scientific excellence, world-renowned universities, and appeal to international talent, has made remarkable strides in recent years—particularly in deeptech and AI, areas that align perfectly with our investment strategy at the continuum of software and science.
In fact, we’ve already backed over 10 UK-based companies, including 9fin, Uncommon, and Hypervision Surgical. With our new office in London, we’re excited to build a stronger on-the-ground presence and to deepen our engagement with the local tech ecosystem, led by our General Partner, Sebastian Becker.
co-creating the future
As we launch RAC VII and expand our presence in London, we’re reinforcing our commitment to backing the most innovative minds in Europe. This new fund is a continuation of our journey, rooted in nearly two decades of experience and a strong belief in the potential of technology to solve real-world challenges.
Together with our founders, investors, and partners, we’re ready and excited to contribute to the next wave of technological breakthroughs—empowering GameChangers, disrupting industries for good, and shaping a better world for all.
Comentários